from Reuters: U.S. http://ift.tt/2lc9uLv
Monday, February 6, 2017
Mylan agreed to pay $96.5 million in Provigil antitrust class action
(Reuters) - Mylan NV has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon Inc's narcolepsy drug Provigil in exchange for payment from Cephalon.
from Reuters: U.S. http://ift.tt/2lc9uLv
from Reuters: U.S. http://ift.tt/2lc9uLv
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment